DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Sanofi – Aventis Groupe
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Medsafe (NZ)
Rilutek (riluzole) is an oral medication used to treat ALS by suppressing the release of glutamate, a neurotransmitter that contributes to the death of nerve cells. It works by reducing the amount of glutamate in the brain and spinal cord, slowing down the progression of ALS.